Liver Transplantation for Portal Hypertension
https://doi.org/10.16931/1995-5464.2015159-65
Abstract
Aim: to evaluate the immediate and remote results of liver transplantation (LT) for portal hypertension syndrome in the
Republic of Belarus. Material and Methods. 256 primary liver transplantation for portal hypertension were included into retrospective study. 30 operations for fulminant hepatic failure (n = 14), unresectable alveococcosis (n = 6) and neoplasms (n = 10) were included into comparison group. Results. There were no differences in incidence of vascular, biliary and infectious complications in both groups. It was revealed that the acute rejection incidence in case of portal hypertension was 8.6% (22 out of 256) vs. 20% (6 out of 30) (р = 0.05) in comparison group. 3-year survival was 88.4% in the main group and 90% in the control group. Conclusion. Liver transplantation is an effective method of treatment for portal hypertension. Portal vein thrombosis in cirrhotic patients is not contraindication for liver transplantation
About the Author
O. O. RummoBelarus
Doct. of Med. Sci., Head of Republican Scientific and Practical Center for Organs and Tissues Transplantation, Minsk
References
1. Manzano-Robleda Mdel C., Barranco-Fragoso B., Uribe M., Mendez-Sanchez N. Portal vein thrombosis: What is new? Ann. Hepatol. 2015; 14 (1): 20–27.
2. Щерба А.Е., Руммо О.О., Слободин Ю.В., Дзядзько А.М., Болонкин Л.С., Сантоцкий Е.О., Авдей Е.Л., Федорук А.М., Пикиреня И.И., Кулинкович И.Л., Харьков Д.П., Козич П.В., Коротков С.В., Кирковский Л.В., Юрле вич Д.И., Жук Г.В., Гордей Е.В., Васюкевич М.А. Ортотопическая трансплантация печени при злокачественных новообразованиях. Онкологический журнал. 2009; 3 (4): 24–31. Shcherba A.E., Rummo O.O., Slobodin Yu.V., Dzyadz‘ko A.M., Bolonkin L.S., Santotskiy E.O., Avdey E.L., Fedoruk A.M., Pikirenya I.I., Kulinkovich I.L., Khar’kov D.P., Kozich P.V., Korotkov S.V., Kirkovskiy L.V., Yurlevich D.I., Zhuk G.V., Gordey E.V., Vasyukevich M.A. Orthotopic liver transplantation for malignant tumors. Onkologicheskij zhurnal. 2009; 3 (4): 24–31. (In Russian)
3. Berry K., Taylor J., Liou I.W., Ioannou G.N. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. Clin. Gastroenterol. Hepatol. 2014; pii: S1542-3565(14)01501-150 8. doi: 10.1016/j.cgh.2014.10.010.
4. Kensinger C.D., Sexton K.W., Baron C.M., Lipnik A.J., Meranze S.G., Gorden D.L. Management of portal vein thrombosis after liver transplantation with a combined open and endovascular approach. Liver Transpl. 2015; 21 (1): 132–134. doi: 10.1002/lt.24011.
5. Szymczak M., Kalicinski P., Kwiatkowski W., Broniszczak D., Stefanowicz M. Cavo-portal transposition in pediatric liver transplant recipients. Ann. Transplant. 2014; 19: 283–287. doi: 10.12659/AOT.890060.
6. Saad W.E. Transjugular intrahepatic portosystemic shunt before and after liver transplantation. Semin. Intervent. Radiol. 2014; 31 (3): 243–247. doi: 10.1055/s-0034-1382791.
7. Israelsen M.E., Gluud L.L., Krag A. Acute kidney injury and hepatorenal syndrome in cirrhosis. J. Gastroenterol. Hepatol. 2015; 30 (2): 236–243. doi: 10.1111/jgh.12709.
8. Руммо О.О., Коротков С.В., Щерба А.Е., Зайцев Ю.В., Юрлевич Д.И., Федорук А.М., Слободин Ю.В., Пикиреня И.И., Авдей Е.Л., Кирковский Л.В., Харьков Д.П. Анатомия печеночной артерии: клиническое значение при трансплантации печени. Анналы хирургической гепатологии. 2011; 16 (3): 72–78. Rummo O.O., Korotkov S.V., Shcherba A.E., Zaitsev Yu.V., Yurlevich D.I., Fedoruk A.M., Slobodin Yu.V., Pikirenya I.I., Avdey E.L., Kirkovskiy L.V., Khar’kov D.P. Hepatic artery anatomy: clinical importance in liver transplantation. Annaly khirurgicheskoy gepatologii. 2011; 16 (3): 72–78. (In Russian)
9. Ulrich F., Pratschke J., Neumann U., Pascher A., Puhl G., Fellmer P., Weiss S., Jonas S., Neuhaus P. Eighteen years of liver transplantation experience in patients with advanced Budd–Chiari syndrome. Liver Transpl. 2008; 14 (2): 144–150. doi: 10.1002/lt.21282.
10. Darwish Murad S., Kamath P.S. Liver transplantation for Budd-Chiari syndrome: When is it really necessary? Liver transplantation. 2008; 14 (2): 133–135. doi: 10.1002/lt.21286.
11. Janssen H.L.A., Darwish Murad S., Henk R. van Buuren. Budd–Chiari syndrome. Portal hypertension: pathogenesis and management. Chapter 21. New York: Nova Science Publishers Inc, 2006. 227 p.
12. Horton J.D., San Miguel F.L., Membreno F., Wright F., Paima J., Foster P., Ortiz J.A. Budd-Chiari syndrome: illustrated review of current management. Liver Int. 2008; 28 (4): 455–466. doi: 10.1111/j.1478-3231.2008.01684.x.
13. Mentha G., Giostra E., Majno P.E., Bechstein W.O., Neuhaus P., O'Grady J., Praseedom R.K., Burroughs A.K., Le Treut Y.P., Kirkegaard P., Rogiers X., Ericzon B.G., Hockerstedt K., Adam R., Klempnauer J. Liver transplantation for Budd–Chiari syndrome: A European study on 248 patients from 51 centres. J. Hepatol. 2006; 44 (3): 520–528.
14. Janssen H.L., Garcia-Pagan J.C., Elias E., Mentha G., Hadengue A., Valla D.C. European Group for the Study of Vascular Disorders of the Liver. Budd–Chiari syndrome: a review by an expert panel. J. Hepatol. 2003; 38 (3): 364–371.
15. Ефимов Д.Ю., Щерба А.Е., Сантоцкий Е.О., Минов А.Ф., Дзядзько А.М., Руммо О.О. Трансплантация печени при фульминантной печеночной недостаточности, вызванной отравлением бледной поганкой. Медицинский журнал. 2013; 4: 4–7. Efimov D.Yu., Shcherba A.E., Santotskiy E.O., Minov A.F., Dzyadz’ko A.M., Rumo O.O. Liver transplantation for amanitainduced fulminant hepatic failure. Medicinskij zhurnal. 2013; 4: 4–7. (In Russian)
16. Efimov D.Yu., Shcherba A.E., Dzyadzko A., Fedoruk A., Avdey E., Santotski Ya., Kulinkovich I., Aleh Rumo. First TIPS experience in the transplant center. Abstracts of the 11th World Congress of the International Hepato-Pancreato-Biliary Association, 22–27 March. 2014, Seoul, Korea. Р. 403.
17. Филоник Д.Ю., Савчук М.М., Щерба А.Е., Руммо О.О. Сосудистые осложнения после ортотопической трансплантации печени. Медицинский журнал. 2014; 2: 34–39. Filonik D.Yu., Savchuk M.M., Shcherba A.E., Rummo O.O. Vascular complications after orthotopic liver transplantation. Medicinskij zhurnal. 2014; 2: 34–39. (In Russian)
18. DeLeve L.D., Valla D.C., Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009; 49 (5): 1729–1764. doi: 10.1002/hep.22772.
19. Mackiewicz A., Kotulski M., Zieniewicz K., Krawczyk M. Results of liver transplantation in the treatment of Budd–Chiari syndrome. Ann. Transplant. 2012; 17 (1): 5–10. doi: 10.12659/AOT.882630.
20. Mancuso A. An update on the management of Budd–Chiari syndrome: the issues of timing and choice of treatment. Eur. J. Gastroenterol. Hepatol. 2015; Published Ahead-of-Print, Post Author Corrections: doi: 10.1097/MEG.0000000000000282.
Review
For citations:
Rummo O.O. Liver Transplantation for Portal Hypertension. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2015;20(1):59-65. (In Russ.) https://doi.org/10.16931/1995-5464.2015159-65